The Sugary Slope of Type II Diabetes to Heart Failure

Tuesday, July 26
11:30 a.m. – 12:30 p.m.
Exhibit Hall Theater 1
Supported by Roche


This panel discussion will evaluate the close link between type II diabetes and heart failure and how we can improve both diagnosis and treatment for patients.  The session will highlight the most important biomarker updates from the recently published HFSA Heart Failure Guidelines as well as the ADA Consensus Report on Type II Diabetes and Heart Failure in an insightful multidisciplinary discussion offering perspectives from respected experts in the field.   The discussion will dive deeper into early identification of patients at risk, multimarker approaches, frequency of monitoring, and innovative diagnostic solutions.



Alexander Fohl, PharmD
Scientific Liaison, Core Lab and Point of Care



Ambarish Pandey, MD, MSCS, FAHA

Assistant Professor of Internal Medicine
Medical Director, Heart Failure with Preserved Ejection Fraction Program
Associate Program Director for Residency Training
Department of Internal Medicine, Division of Cardiology
UT Southwestern Medical Center, Dallas, Texas

Ibrahim A. Hashim,  MSc, PhD, FIBMS, CSc, DABCC, FAACC
Professor, Arthur J. Gill Professorship in Pathology
Chief of Clinical Pathology, Clinical Chemistry Director,
University of Texas Southwestern Medical Center, Parkland Memorial Hospital, Dallas, Texas

David C. Klonoff, M.D., FACP, FRCP (Edin), Fellow AIMBE    
Medical Director, Diabetes Research Institute
Mills-Peninsula Medical Center, San Mateo
Clinical Professor of Medicine, U.C. San Francisco
Editor-in-Chief, Journal of Diabetes Science and Technology